Pharma Friday: FDA OKs Rasonque for Metastatic Pancreatic Cancer and Mounjaro CV Approval — Sept 4
This Pharma Friday roundup reports two major FDA actions announced in late August 2026: approval of **Rasonque (daraxonrasib)** for previously treated metastatic pancreatic adenocarcinoma, and approva...